Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10967219 | Vaccine | 2013 | 8 Pages |
Abstract
⺠Recent investments significantly reduced mortality and morbidity from measles and rubella. ⺠Measles and rubella still continue to significantly impact the lives of many people globally. ⺠GVAP implementation will require stakeholders to coordinate and make sustained investments. ⺠The methods and assumptions used to value GVAP investments will impact economic estimates. ⺠Timing of the investments matters.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kimberly M. Thompson, Peter M. Strebel, Alya Dabbagh, Thomas Cherian, Stephen L. Cochi,